Cardio Metabolic Unit (CMU)

CMU is a research constellation driving innovative and implementable research and education, closely integrated with specialized health care. In line with its translational approach, CMU is linked to the Department of Medicine, Huddinge and Department of Laboratory Medicine at Campus Flemingsberg.

CMU aims to improve the prevention, diagnosis and treatment of cardiometabolic diseases such as dyslipidemia, atherosclerosis, diabetes, NAFLD/NASH. Molecular mechanisms of genetic, dietary and hormonal regulation of cholesterol, triglyceride, bile acid, and lipoprotein metabolism are explored in human and preclinical models. Influence of diurnal rhythms, microbiota, and novel drugs are studied, also in major collaborations with industry. Members participate in national and international networks of associations and foundations, participate in multicenter clinical trials, and serve as experts in pathophysiology and pharmacology, molecular biology, biochemistry, genomics, cell-based systems, and mass spectrometry.

Coordinator

Paolo Parini

Professor/senior physician
H5 Department of Laboratory Medicine

Team leaders

Bo Angelin

Professor
H7 Department of Medicine, Huddinge

Jonas Brinck

Affiliated to research
H7 Department of Medicine, Huddinge

Mats Eriksson

Affiliated to research
H7 Department of Medicine, Huddinge

Cecilia Morgantini

Affiliated to research

David Nathanson

Affiliated to research
H7 Department of Medicine, Huddinge

Paolo Parini

Professor/senior physician
H5 Department of Laboratory Medicine

Mats Rudling

Affiliated to research
H7 Department of Medicine, Huddinge

Sara Straniero

Affiliated to research
H7 Department of Medicine, Huddinge

Uwe Tietge

Professor/clinical chemist
H5 Department of Laboratory Medicine
H5 Department of Laboratory Medicine
PP
Content reviewer:
03-05-2023